666

DIAMOND BIOFUND INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪27.81 B‬TWD
−1.85TWD
‪−2.58 B‬TWD
‪2.24 M‬TWD
‪190.75 M‬
Beta (1Y)
0.79

About DIAMOND BIOFUND INC


Sector
CEO
Shu Ling Cheng
Headquarters
Taipei
Founded
2013
ISIN
TW0006901002
FIGI
BBG018T91S34
Diamond BioFund Inc. operates as an investment company in medical research, medical equipment, medical service technology and agricultural technology areas. The company was founded on January 9, 2013 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6901 is 32.30 TWD — it has decreased by −1.07% in the past 24 hours. Watch DIAMOND BIOFUND INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange DIAMOND BIOFUND INC stocks are traded under the ticker 6901.
6901 stock has risen by 0.31% compared to the previous week, the month change is a −17.50% fall, over the last year DIAMOND BIOFUND INC has showed a −37.16% decrease.
6901 reached its all-time high on Nov 10, 2023 with the price of 57.20 TWD, and its all-time low was 31.10 TWD and was reached on Nov 14, 2024. View more price dynamics on 6901 chart.
See other stocks reaching their highest and lowest prices.
6901 stock is 2.17% volatile and has beta coefficient of 0.79. Track DIAMOND BIOFUND INC stock price on the chart and check out the list of the most volatile stocks — is DIAMOND BIOFUND INC there?
Yes, you can track DIAMOND BIOFUND INC financials in yearly and quarterly reports right on TradingView.
DIAMOND BIOFUND INC is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
6901 net income for the last quarter is ‪−811.15 M‬ TWD, while the quarter before that showed ‪−134.07 M‬ TWD of net income which accounts for −505.04% change. Track more DIAMOND BIOFUND INC financial stats to get the full picture.
Yes, 6901 dividends are paid annually. The last dividend per share was 0.20 TWD. As of today, Dividend Yield (TTM)% is 0.52%. Tracking DIAMOND BIOFUND INC dividends might help you take more informed decisions.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DIAMOND BIOFUND INC EBITDA is ‪−691.72 M‬ TWD, and current EBITDA margin is ‪−115.50 K‬%. See more stats in DIAMOND BIOFUND INC financial statements.
Like other stocks, 6901 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DIAMOND BIOFUND INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DIAMOND BIOFUND INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DIAMOND BIOFUND INC stock shows the sell signal. See more of DIAMOND BIOFUND INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.